---
schema_version: "secwatch.filing_event.v1"
accession: "0001568651-26-000066"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2026-08-06T10:08:21+00:00"
generated_at: "2026-08-06T10:10:46.927484+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Oscar Health Q2 net income $361.8M vs loss $228.4M; raises FY 2026 guidance

## Summary
- Q2 2026 total revenue $4.88B, up 70% YoY; net income $361.8M ($1.10 diluted EPS) vs net loss $228.4M ($0.89 loss) in Q2 2025.
- Medical loss ratio improved to 79.2% from 91.1%; SG&A expense ratio improved to 14.2% from 18.7%.
- Effectuated membership grew 46% YoY to 2.96M members.
- Full-year 2026 earnings from operations guidance raised to $500M-$700M (from $250M-$450M); MLR guidance improved to 81.5%-82.5%.
- Adjusted EBITDA $415.3M in Q2 2026 vs loss $199.4M in Q2 2025.

## SEC filing metadata
- accession: 0001568651-26-000066
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2026-08-06T10:08:21+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000156865126000066/0001568651-26-000066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000156865126000066/oscr-20260806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001568651-26-000066
- JSON: https://secwatch.observer/filing/0001568651-26-000066.json
- Plain text: https://secwatch.observer/filing/0001568651-26-000066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.